The Eclosion Process


Submit a project

 

How to start

Our job is to help you evaluate and realise the potential of your innovation.

If you have an innovative life sciences project, contact us for help with defining

  • Its potential
    In a competitive market, the way in which you decide whether to go ahead is fundamentally important. We can help you to make this decision on an informed and reasoned basis.
  • A proof of concept plan
    Innovations with strong potential often have multiple applications. If you are to prove the benefits of your project, you must decide which applications to pursue.

Send us an application

We don’t need a long document with fancy graphics or a business plan: if you think your innovation has potential, simply send us a non-confidential description of its results, published and otherwise, so that we can assess whether it matches our objectives.

Based on this, we’ll decide whether we want to be involved, and may ask you to sign a confidentiality agreement before we begin discussions with you.

We support projects during the startup phase. We’re less interested in whether you’ve already set up the company and in the detailed scientific background: what matters to us is the innovation and its potential. 



 

Selection criteria

Selected projects must have the potential to make significant and lasting improvements to patient health.

This is dependent on four factors:

  • Market demand: Is there is a real medical need for the innovation?
  • Significant improvement: Is the product more effective than others on the market or in development?
  • Applicability: Does the discovery represent the state of the art and have the potential to be commercially exploited?
  • Compatibility: Can our resources add real value to your idea?

Areas we cover

Eclosion supports new, innovative life science projects with strong potential for human medicine.


This includes the following, among others:

  • Pharmaceutical development
  • Medical biotechnology
  • Vaccines
  • Medical diagnostics
  • Medical technology
  • Drug formulation and administration
  • Medical use of IT (bioinformatics)




 

The selection process

Objectifs retenus

Description

Analyse applications (1 to 3 months)

Stage A

We work with you to determine, as quickly as possible, your innovation’s potential for success based on the complex development process involved in this industry. If this potential exists, we move to stage B.

Detailed evaluation of application, with a view to drawing up a project plan (3 to 12 months)

Stage B

We carry out a more detailed analysis of the project’s development potential based on therapeutic, manufacturing, regulatory and commercial considerations. This phase involves a large number of experts. If it is successful, we draw up a realistic development plan enabling you to achieve your objectives.

Experimental evaluation of the technology/product (averages 1 to 2 years; varies a great deal)

Stage C

You begin the therapeutic proof of principle phase, using equipment and other resources provided by us. If this is successful, we’ll help you to launch the startup. 

Where the project is not selected, provide guidance on other possible sources of help

Stage D

If we don’t believe your project fits our objectives, we’ll try to put you in touch with other bodies that may be able to help.